We would like to inform all participants, speakers, and attendees that the ICPOC 2026 event scheduled during November 23-25, 2026 in Singapore and Online has been postponed. The decision has been made to ensure the best possible experience for everyone involved. The new dates will be announced soon and updated on our website. We sincerely appreciate your understanding and continued support.
For any queries, please contact: [email protected]
We are excited to bring you an even bigger and better event!
Please stay tuned for updated details, which will be shared soon.
Jiangxi Cancer Hospital & Institute, China
Dr. Tenghua Yu is a clinician specializing in breast cancer research and treatment. He currently serves as Associate Chief Physician and Deputy Director of the Breast Surgery Department at Jiangxi Cancer Hospital & Institute, China. Dr. Yu earned his PHD (2013-2016) from Chongqing Medical University, China. From November 2024 to April 2025, Dr. Yu conducted advanced research at the UChicago Medical Center, USA. His research focuses on the tumor microenvironment, particularly the role of GPER in therapeutic resistance, and has authored over 30 peer-reviewed articles in international journals, including Oncogene, Clinical and Translational Medicine, Molecular Cell Endocrinology et al.
Oral Presentation (Virtual)
© 2026 Mathews International LLC. All rights reserved.
